C. difficile diagnostics
Clostridium difficile is the major cause
of nosocomial diarrhea and pseudomembranous colitis
C. difficile infection usually occurs when the normal microflora of the intestinal tract is altered or killed by antibiotics. Once C. difficile growth begins, toxins A and B are produced, causing diarrhea and colitis.
The disease can be treated with metronidazole or vancomycin, but relapses occur in about 20% of patients who develop the infection.
TECHLAB produces a panel of in vitro diagnostics for detecting C. difficile and its toxins in fecal specimens from patients suspected of having the disease.
For more information about TechLab and their products/services
click on the following link: http://www.techlab.com/
“The C Diff Foundation’s mission is to educate and advocate for Clostridium difficile infection prevention, treatments, support, and environmental safety worldwide.
The C Diff Foundation’s organization is comprised of 100% volunteering members who are dedicated to our mission and adhere to the Foundation’s Code of Ethics
which prohibits paid endorsements or paid promotion of products, services, medications, or clinical studies in progress. All website entries, public presentations, and workshops are to raise C. diff. infection awareness in all areas of the C Diff Foundation’s mission statement, including infection prevention, treatments, environmental safety products, diagnostics, sepsis, healthcare-associated infections, antimicrobial resistance, antibiotic stewardship and provide education on all the above.”